» Articles » PMID: 15821464

Evaluation and Management of Renal Tumors in the Birt-Hogg-Dubé Syndrome

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2005 Apr 12
PMID 15821464
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Herein we describe the evaluation and management of renal tumors in Birt-Hogg-Dubé (BHD), an autosomal dominant disorder predisposing to cutaneous fibrofolliculomas, pulmonary cysts, spontaneous pneumothorax and renal tumors.

Materials And Methods: A total of 124 affected individuals underwent comprehensive clinical evaluation, including body computerized tomography, to determine cutaneous, pulmonary and renal manifestations of BHD. Of these individuals 14 had their renal tumors managed at our institution.

Results: Of the 124 BHD affected individuals 34 (27%) had renal tumors of various histologies, most commonly hybrid oncocytic tumor and chromophobe renal carcinoma. Average age at renal tumor detection was 50.4 years and multiple tumors were found in a majority of patients. Some patients with renal tumors were identified that did not have the characteristic cutaneous hallmarks of BHD. In 4 of the 14 patients treated at our institution small (less than 3 cm) renal tumors were observed, while 10 others underwent a total of 12 renal procedures, including 4 radical and 8 partial nephrectomies. At a median of 38 months of followup 5 of these 10 patients remained free of disease, 3 had small renal tumors and 2 died of metastatic renal cancer.

Conclusions: Patients with BHD are at risk for multiple renal tumors that are often malignant and can metastasize. Individuals at risk or affected by BHD should be radiographically screened for renal tumors at periodic intervals and they are best treated with nephron sparing surgical approaches. Genetic testing for this syndrome is now available.

Citing Articles

Diagnosis of renal tumors in Birt-Hogg-Dube syndrome: Clinical presentation and risk factors in a single-center retrospective cohort.

Kijlertsuphasri S, Petnak T, Moua T BMC Nephrol. 2024; 25(1):329.

PMID: 39354434 PMC: 11446078. DOI: 10.1186/s12882-024-03775-9.


Clinical and genetic characteristics of 100 consecutive patients with Birt-Hogg-Dubé syndrome in Eastern Chinese region.

Hu D, Wang R, Liu J, Chen X, Jiang X, Xiao J Orphanet J Rare Dis. 2024; 19(1):348.

PMID: 39300538 PMC: 11414263. DOI: 10.1186/s13023-024-03360-1.


Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.

Cicchetti R, Basconi M, Litterio G, Mascitti M, Tamborino F, Orsini A Int J Mol Sci. 2024; 25(16).

PMID: 39201746 PMC: 11355026. DOI: 10.3390/ijms25169060.


ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndrome.

Geilswijk M, Genuardi M, Woodward E, Nightingale K, Huber J, Madsen M Eur J Hum Genet. 2024; 32(12):1542-1550.

PMID: 39085584 PMC: 11607457. DOI: 10.1038/s41431-024-01671-2.


Birt-Hogg-Dubé Syndrome: A Rare Genodermatosis Presenting as Skin Papillomas.

Theodorakopoulou E, McCarthy A, Almpanis Z, Aguilera S Aesthet Surg J Open Forum. 2023; 5:ojad064.

PMID: 37520842 PMC: 10373902. DOI: 10.1093/asjof/ojad064.